1. Home
  2. STRS vs ACIU Comparison

STRS vs ACIU Comparison

Compare STRS & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stratus Properties Inc.

STRS

Stratus Properties Inc.

HOLD

Current Price

$29.90

Market Cap

241.5M

Sector

Real Estate

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.03

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRS
ACIU
Founded
1992
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.5M
213.3M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
STRS
ACIU
Price
$29.90
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
14.6K
240.0K
Earning Date
05-14-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
512.50
N/A
EPS
1.47
N/A
Revenue
$29,914,000.00
N/A
Revenue This Year
N/A
$706.75
Revenue Next Year
N/A
$321.13
P/E Ratio
$20.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.28
$1.45
52 Week High
$32.93
$4.00

Technical Indicators

Market Signals
Indicator
STRS
ACIU
Relative Strength Index (RSI) 46.80 50.44
Support Level $28.22 $2.56
Resistance Level $31.30 $3.46
Average True Range (ATR) 1.00 0.20
MACD -0.08 0.02
Stochastic Oscillator 10.43 51.60

Price Performance

Historical Comparison
STRS
ACIU

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations. Real Estate Operations segment encompasses activities associated with entitlement, development, and sale of real estate. Leasing Operations segment involves leasing of commercial space at retail and mixed-use properties and residences in multi-family properties that company developed. Majority of revenue is from Real Estate Operations.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: